4-Methyl-1H-benzimidazole-2-carboxylic acid

Catalog No. :
ACEMQJ042
CAS No. :
673487-32-6
Molecular Formula :
C9H8N2O2
Molecular Weight :
176.18

IUPAC Name:4-methyl-1H-benzo[d]imidazole-2-carboxylic acid

4-Methyl-1H-benzimidazole-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$65.00Login to see priceIn stockIn stock
5g95%$236.00Login to see priceIn stockIn stock
25g95%$912.00Login to see priceIn stockInquiry
100g95%$2977.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-1H-benzimidazole-2-carboxylic acid
IUPAC Name4-methyl-1H-benzo[d]imidazole-2-carboxylic acid
MDL No.MFCD09751735
Molecular FormulaC9H8N2O2
Molecular Weight176.18
SMILESCC1=CC=CC2=C1N=C([NH]2)C(=O)O
InChI KeyOBQMQANOQQJNFK-UHFFFAOYSA-N
Synonym4-Methyl-1H-benzimidazole-2-carboxylic acid;7-methyl-1H-benzo[d]imidazole-2-carboxylic acid;4-Methyl-1H-benzoimidazole-2-carboxylic acid;1H-Benzimidazole-2-carboxylicacid,4-methyl-(9CI);4-Methyl-1H-1,3-benzodiazole-2-carboxylic acid;4-Methyl-1H-benzo[d]iMidazole-2-carboxylic acid;7-Methyl-1H-BenziMidazole-2-carboxylic Acid;1H-Benzimidazole-2-carboxylic acid, 7-methyl-
CAS No.673487-32-6
PubChem CID42609118

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACEMQJ042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMQJ042 route product structure diagram
    ACEMQJ042673487-32-6 In Stock
Inquiry

2. ACEMQJ042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMQJ042 route product structure diagram
    ACEMQJ042673487-32-6 In Stock
Inquiry

Comments (0)